0152 GMT - Pro Medicus loses its bull at Jefferies, where analysts think the market is being overly optimistic about the imaging-tech provider's prospects for U.S. market-share growth. The investment bank's analysts tell clients in a note that they think the market is pricing in a 51% share of the U.S. picture-archiving and communication system market by fiscal 2035. This is too aggressive, they say. However, they are more positive about Pro Medicus's resilience to AI threats and think the technology is more likely to enhance the value proposition of the company's Visage product suite. Jefferies lowers its recommendation on the stock to hold from buy but lifts its target price by 13% to 192.60 Australian dollars. Shares are down 2.1% at A$207.62. (stuart.condie@wsj.com)

(END) Dow Jones Newswires

July 08, 2026 21:52 ET (01:52 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.